Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$11.25 - $14.75 $1.22 Million - $1.59 Million
-108,100 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$10.69 - $16.49 $53,450 - $82,449
5,000 Added 4.85%
108,100 $1.23 Million
Q1 2020

May 13, 2020

BUY
$9.78 - $29.53 $149,634 - $451,809
15,300 Added 17.43%
103,100 $1.48 Million
Q4 2019

Feb 14, 2020

BUY
$20.93 - $35.1 $152,789 - $256,230
7,300 Added 9.07%
87,800 $2.39 Million
Q3 2019

Nov 08, 2019

SELL
$22.08 - $47.08 $302,496 - $644,996
-13,700 Reduced 14.54%
80,500 $2.31 Million
Q2 2019

Aug 09, 2019

SELL
$22.67 - $35.0 $102,015 - $157,500
-4,500 Reduced 4.56%
94,200 $2.62 Million
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $185,817 - $239,430
6,900 Added 7.52%
98,700 $3.28 Million
Q4 2018

Feb 12, 2019

BUY
$27.23 - $45.56 $234,178 - $391,816
8,600 Added 10.34%
91,800 $2.67 Million
Q3 2018

Nov 05, 2018

BUY
$37.57 - $50.34 $371,943 - $498,366
9,900 Added 13.51%
83,200 $3.83 Million
Q2 2018

Aug 14, 2018

SELL
$27.75 - $40.17 $560,550 - $811,434
-20,200 Reduced 21.6%
73,300 $2.74 Million
Q1 2018

Apr 30, 2018

SELL
$28.83 - $41.01 $11,532 - $16,404
-400 Reduced 0.43%
93,500 $2.76 Million
Q4 2017

Feb 12, 2018

SELL
$28.45 - $37.14 $1.33 Million - $1.74 Million
-46,800 Reduced 33.26%
93,900 $3.23 Million
Q3 2017

Nov 13, 2017

BUY
$24.01 - $36.2 $151,263 - $228,060
6,300 Added 4.69%
140,700 $5.09 Million
Q2 2017

Aug 14, 2017

BUY
N/A
134,400
134,400 $0

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.03B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.